 Deamino Arginine Vasopressin
"Deamino Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.
| Descriptor ID |
D003894
|
| MeSH Number(s) |
D06.472.699.631.692.781.100.250 D12.644.400.900.100.250 D12.644.456.925.100.250 D12.644.548.691.692.781.100.250 D12.776.631.650.937.100.250
|
| Concept/Terms |
Deamino Arginine Vasopressin- Deamino Arginine Vasopressin
- Arginine Vasopressin, Deamino
- 1-Desamino-8-arginine Vasopressin
- Vasopressin, 1-Desamino-8-arginine
- Desmopressin
- Vasopressin, Deamino Arginine
- 1-Deamino-8-D-arginine Vasopressin
- Vasopressin, 1-Deamino-8-D-arginine
DDAVP- DDAVP
- Octostim
- Desmotabs
- Octim
- Desmopressine Ferring
- Ferring, Desmopressine
- Desmospray
Desmopressin Acetate- Desmopressin Acetate
- Acetate, Desmopressin
- Desmopressin Monoacetate, Trihydrate
- Monoacetate, Trihydrate Desmopressin
- Trihydrate Desmopressin Monoacetate
|
Below are MeSH descriptors whose meaning is more general than "Deamino Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Deamino Arginine Vasopressin".
This graph shows the total number of publications written about "Deamino Arginine Vasopressin" by people in this website by year, and whether "Deamino Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 1 | 2 | | 2005 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2017 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Deamino Arginine Vasopressin" by people in Profiles.
-
Yorkgitis BK, Tatum DM, Taghavi S, Schroeppel TJ, Noorbakhsh MR, Philps FH, Bugaev N, Mukherjee K, Bellora M, Ong AW, Ratnasekera A, Nordham KD, Carrick MM, Haan JM, Lightwine KL, Lottenberg L, Borrego R, Cullinane DC, Berne JD, Rodriguez Mederos D, Hayward TZ, Kerwin AJ, Crandall M. Eastern Association for the Surgery of Trauma Multicenter Trial: Comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients. J Trauma Acute Care Surg. 2022 01 01; 92(1):88-92.
-
Barinsky GL, Buziashvili D, Svider PF, Carron MA, Folbe AJ, Hsueh WD, Eloy JA, Johnson AP. Perioperative Desmopressin for Patients Undergoing Otolaryngologic Procedures: A Systematic Review. Otolaryngol Head Neck Surg. 2019 07; 161(1):36-45.
-
Ng CJ, Di Paola J. von Willebrand Disease: Diagnostic Strategies and Treatment Options. Pediatr Clin North Am. 2018 06; 65(3):527-541.
-
Lehmann M, Ashworth K, Manco-Johnson M, Di Paola J, Neeves KB, Ng CJ. Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels. J Thromb Haemost. 2018 01; 16(1):104-115.
-
Roncal-Jimenez CA, Milagres T, Andres-Hernando A, Kuwabara M, Jensen T, Song Z, Bjornstad P, Garcia GE, Sato Y, Sanchez-Lozada LG, Lanaspa MA, Johnson RJ. Effects of exogenous desmopressin on a model of heat stress nephropathy in mice. Am J Physiol Renal Physiol. 2017 03 01; 312(3):F418-F426.
-
Hopp K, Hommerding CJ, Wang X, Ye H, Harris PC, Torres VE. Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. J Am Soc Nephrol. 2015 Jan; 26(1):39-47.
-
Li C, Wang W, Rivard CJ, Lanaspa MA, Summer S, Schrier RW. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am J Physiol Renal Physiol. 2011 May; 300(5):F1255-61.
-
Madden JR, Dobyns E, Handler M, Foreman NK. Experience with electrolyte levels after craniotomy for pediatric brain tumors. J Pediatr Oncol Nurs. 2010 Jan-Feb; 27(1):21-3.
-
Sharthkumar A, Greist A, Di Paola J, Winay J, Roberson C, Heiman M, Herbert S, Parameswaran R, Shapiro A. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease. Haemophilia. 2008 May; 14(3):539-48.
-
Lyon C, Schnall J. What is the best treatment for nocturnal enuresis in children? J Fam Pract. 2005 Oct; 54(10):905-6, 909.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|